NM_001244008.2:c.4927G>A

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1

The NM_001244008.2(KIF1A):​c.4927G>A​(p.Asp1643Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000459 in 1,611,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1643E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00047 ( 0 hom. )

Consequence

KIF1A
NM_001244008.2 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:4

Conservation

PhyloP100: 5.32

Publications

11 publications found
Variant links:
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
KIF1A Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuropathy, hereditary sensory, type 2C
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 30
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • PEHO syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.072295696).
BP6
Variant 2-240719868-C-T is Benign according to our data. Variant chr2-240719868-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211292.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000473 (691/1459584) while in subpopulation MID AF = 0.00304 (17/5600). AF 95% confidence interval is 0.00193. There are 0 homozygotes in GnomAdExome4. There are 348 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001244008.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF1A
NM_001244008.2
MANE Select
c.4927G>Ap.Asp1643Asn
missense
Exon 46 of 49NP_001230937.1
KIF1A
NM_001379631.1
c.5002G>Ap.Asp1668Asn
missense
Exon 46 of 49NP_001366560.1
KIF1A
NM_001379642.1
c.4927G>Ap.Asp1643Asn
missense
Exon 46 of 49NP_001366571.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF1A
ENST00000498729.9
TSL:5 MANE Select
c.4927G>Ap.Asp1643Asn
missense
Exon 46 of 49ENSP00000438388.1
KIF1A
ENST00000460788.5
TSL:1
n.1484G>A
non_coding_transcript_exon
Exon 6 of 9
KIF1A
ENST00000492812.6
TSL:1
n.3510G>A
non_coding_transcript_exon
Exon 13 of 16

Frequencies

GnomAD3 genomes
AF:
0.000322
AC:
49
AN:
152196
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000362
AC:
89
AN:
245806
AF XY:
0.000388
show subpopulations
Gnomad AFR exome
AF:
0.000196
Gnomad AMR exome
AF:
0.000204
Gnomad ASJ exome
AF:
0.000303
Gnomad EAS exome
AF:
0.000224
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000489
Gnomad OTH exome
AF:
0.000336
GnomAD4 exome
AF:
0.000473
AC:
691
AN:
1459584
Hom.:
0
Cov.:
30
AF XY:
0.000479
AC XY:
348
AN XY:
726072
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33434
American (AMR)
AF:
0.000246
AC:
11
AN:
44640
Ashkenazi Jewish (ASJ)
AF:
0.000307
AC:
8
AN:
26060
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39642
South Asian (SAS)
AF:
0.000546
AC:
47
AN:
86150
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52356
Middle Eastern (MID)
AF:
0.00304
AC:
17
AN:
5600
European-Non Finnish (NFE)
AF:
0.000506
AC:
562
AN:
1111416
Other (OTH)
AF:
0.000531
AC:
32
AN:
60286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
38
77
115
154
192
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000322
AC:
49
AN:
152314
Hom.:
0
Cov.:
33
AF XY:
0.000255
AC XY:
19
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41562
American (AMR)
AF:
0.000261
AC:
4
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5180
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000441
AC:
30
AN:
68018
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.532
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000475
Hom.:
1
Bravo
AF:
0.000340
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000359
AC:
3
ExAC
AF:
0.000373
AC:
45
EpiCase
AF:
0.000654
EpiControl
AF:
0.000892

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:4Benign:1
Aug 01, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 28, 2018
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 20, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 09, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30564185)

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KIF1A: PM2

not specified Uncertain:1Benign:1
May 15, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 19, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: KIF1A c.4624G>A (p.Asp1542Asn) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00036 in 245806 control chromosomes (gnomAD). c.4624G>A has been reported in the literature in an individual affected with Hereditary Spastic Paraplegia without strong evidence of causality (D'Amore_2018). This report does not provide unequivocal conclusions about association of the variant with Hereditary Spastic Paraplegia 30. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication haz been ascertained in the context of this evaluation (PMID: 30564185). ClinVar contains an entry for this variant (Variation ID: 211292). Based on the evidence outlined above, the variant was classified as likely benign.

Intellectual disability, autosomal dominant 9 Uncertain:1
Jan 01, 2019
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Neuropathy, hereditary sensory and autonomic, type 2A;C3280168:Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Jul 24, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
22
DANN
Benign
0.79
DEOGEN2
Benign
0.16
T
Eigen
Benign
-0.48
Eigen_PC
Benign
-0.46
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.93
D
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.072
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L
PhyloP100
5.3
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.053
Sift
Benign
0.39
T
Sift4G
Benign
0.25
T
Polyphen
0.30
B
Vest4
0.22
MVP
0.65
MPC
0.60
ClinPred
0.016
T
GERP RS
4.2
Varity_R
0.088
gMVP
0.29
Mutation Taster
=22/78
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200141437; hg19: chr2-241659285; API